In Supplementary Table 3 of the article cited above, for LDL-cholesterol, the adjusted mean (SE) change from baseline [rather than baseline] in difference vs. linagliptin 5 mg for empagliflozin 25 mg/linagliptin 5 mg should be 0.1 (0.1) mmol/L; P = 0.155. The online version reflects these changes.
© 2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.
2015